Hind Bio-Pharmaceuticals Limited

Hind Bio-Pharmaceuticals Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24231DL2006PLC146918 Incorporated 28 February 2006 ROC Delhi HQ Delhi, India
Struck Off Public Limited Company chemicals
Revenue · FY 2018
₹62.69 Lakh
▲ 24974% YoY
Net profit · FY 2018
₹62.59 Lakh
Net margin 99.9%
EBITDA · FY 2018
₹62.63 Lakh
EBITDA margin 99.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
3
As per MCA filings
Last financials
Mar 2018
Balance sheet date

About Hind Bio-Pharmaceuticals Limited

Data last updated:

Hind Bio-Pharmaceuticals Limited was a public limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 28 February 2006.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2006PLC146918.

The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It was led by directors including Samar Qureshi and Kiran Qureshi.

Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at B – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065.

As per the financials filed for FY 2018, the company reported a revenue of ₹62.69 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹62.59 Lakh (net margin 99.9%) and EBITDA of ₹62.63 Lakh (EBITDA margin 99.9%). Revenue has grown at a compounded annual rate (CAGR) of 945% over three years.

Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

The last known website on record is hind.in.

Company details

CIN U24231DL2006PLC146918
Registration Number 146918
Incorporation Date 28 February 2006
ROC Delhi
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Non-Compliant

Contact details

Hind Bio-Pharmaceuticals Limited's registered office is in Delhi, Delhi.

  • Registered Address
    B – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
Comprehensive company report
Hind Bio-Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Hind Bio-Pharmaceuticals Limited

FY 2018 filings available

Hind Bio-Pharmaceuticals Limited reported revenue of ₹62.69 Lakh (up 24974% YoY) for FY 2018.

Revenue · FY 2018
₹62.69 Lakh ▲ 24974%
Net profit · FY 2018
₹62.59 Lakh margin 99.9%
EBITDA · FY 2018
₹62.63 Lakh margin 99.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 945%
EBITDA CAGR growth
3 years · compounded
▲ 531%

Revenue has grown at a compounded annual rate (CAGR) of 945% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹62.63 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹62.59 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin99.9%
Net Profit Margin99.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hind Bio-Pharmaceuticals Limited, buy the company report.

Board of directors of Hind Bio-Pharmaceuticals Limited

Hind Bio-Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Samar QureshiDirector30 Dec 201510 Years 10 MonthsAs last reported
Kiran QureshiDirector28 Feb 200620 Years 8 MonthsAs last reported
Sirajuddin QureshiDirector28 Feb 200620 Years 8 MonthsAs last reported

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hind Bio-Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Hind Bio-Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Hind Bio-Pharmaceuticals Limited has 5 board changes on record since 2006: 3 appointments and 2 cessations. The latest: Samar Qureshi ceased to be Additional Director on 30 Sep 2016.

AGM
Hind Bio-Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Filing
Hind Bio-Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi.
Ceased
Samar Qureshi ceased to be Additional Director.
Ceased
Surendra Kumar Ranjhan ceased to be Director.
Appointed
Samar Qureshi was appointed as Director.
Appointed
Kiran Qureshi was appointed as Director.
Appointed
Sirajuddin Qureshi was appointed as Director.
Incorporation
28 Feb 2006
Hind Bio-Pharmaceuticals Limited was registered on 28 Feb 2006 with Roc Delhi & aged 20 years 8 months as per MCA records.

Frequently asked questions

Hind Bio-Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Hind Bio-Pharmaceuticals was a public limited company based in Delhi, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 28 February 2006 and is registered under CIN U24231DL2006PLC146918. The company has been struck off by the Registrar of Companies and is no longer operational.

Hind Bio-Pharmaceuticals had 3 directors:

The CIN (Corporate Identification Number) of Hind Bio-Pharmaceuticals is U24231DL2006PLC146918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Hind Bio-Pharmaceuticals is at B – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065.

Hind Bio-Pharmaceuticals was incorporated on 28 February 2006. It is registered with the Registrar of Companies, Delhi.

Hind Bio-Pharmaceuticals can be reached through the website hind.in. Its registered office is in Delhi, India.

The latest financial statements of Hind Bio-Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.

Hind Bio-Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.

Hind Bio-Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.